ThinkPatternGet the app
Story
BUSINESS · NOV 20, 2026

Missouri Judge Approves $7.25 Billion Roundup Cancer Settlement

A Missouri judge approved a $7.25 billion settlement for U.S. Roundup users alleging the weedkiller caused non-Hodgkin lymphoma, providing payouts between $10,000 and $165,000.

A St. Louis Circuit Judge approved a $7.25 billion nationwide settlement on Friday to resolve thousands of lawsuits alleging that Bayer AG's Roundup weedkiller causes non-Hodgkin lymphoma. Judge Timothy Boyer ruled the agreement fair, reasonable, and adequate, noting that the total amount is among the largest in the history of mass tort personal-injury class action settlements. The deal covers current and future U.S. claims, with individual payouts estimated between $10,000 and $165,000 based on illness severity, diagnosis date, and usage history.

Bayer will fund the settlement through annual contributions to a trust over a period of up to 21 years. The agreement includes $600 million for attorneys' fees and follows a June Supreme Court of the United States ruling that barred state-level failure-to-warn claims, significantly narrowing the legal path for plaintiffs. Judge Boyer indicated that without this settlement, Bayer might have sought bankruptcy protection.

Bayer, which acquired Monsanto in 2018, continues to deny that the active ingredient glyphosate causes cancer and has already modified the product's formula for residential users. CEO Bill Anderson described the court's approval as a decisive milestone in the company's strategy to mitigate litigation risks. While some attorneys criticized the payouts as too small, others viewed the deal as a necessary alternative to a total loss of recovery following the Supreme Court's restrictive ruling.


Reported across 295 outlets
Actors
Bayer AGTimothy BoyerBill AndersonSupreme Court of the United States

Keep reading in the app

The full story and every source, free in the app.